Showing 1,141 - 1,160 results of 2,284 for search '"Cardiovascular disease"', query time: 0.07s Refine Results
  1. 1141

    Association between NAFLD and liver fibrosis with nutritional risk index based on the NHANES 2017–2018 by Jieming Jian, Rui Zhang, Yuan Dong, Hongting Zheng, Xiaoyu Liao

    Published 2025-01-01
    “…The nutritional risk index (NRI) has been widely recognized as a valid indicator of nutritional status in several diseases, including osteoporosis and cardiovascular disease. However, the role of NRI in NAFLD and liver fibrosis remains unclear. …”
    Get full text
    Article
  2. 1142

    Lipoprotein(a) and thromboembolism: current state of knowledge and unsolved issues by Małgorzata Konieczyńska, Joanna Natorska, Michał Ząbczyk, Anetta Undas

    Published 2024-12-01
    “…Lipoprotein(a) [Lp(a)], a low-density lipoprotein-like particle containing a highly polymorphic apolipoprotein(a) [apo(a)] homologous in > 80% to plasminogen, was identified as a genetically determined independent risk factor for cardiovascular disease. Elevated Lp(a) levels, found in about 20% of Europeans, are strongly linked to higher rates of myocardial infarction, major adverse cardiac events, accelerated plaque progression, ischemic stroke (especially in younger adults), and calcific aortic valve disease. …”
    Get full text
    Article
  3. 1143
  4. 1144

    Cardiovascular Risk Assessment: A Comparison of the Framingham, PROCAM, and DAD Equations in HIV-Infected Persons by Max Weyler Nery, Celina Maria Turchi Martelli, Erika Aparecida Silveira, Clarissa Alencar de Sousa, Marianne de Oliveira Falco, Aline de Cássia Oliveira de Castro, Jorge Tannus Esper, Luis Carlos Silva e Souza, Marília Dalva Turchi

    Published 2013-01-01
    “…This study aims to estimate the risk of cardiovascular disease (CVD) and to assess the agreement between the Framingham, Framingham with aggravating factors, PROCAM, and DAD equations in HIV-infected patients. …”
    Get full text
    Article
  5. 1145

    Ezetimibe Anticancer Activity via the p53/Mdm2 Pathway by Charmy Twala, Sibusiso Malindisa, Chamone Munnik, Selisha Sooklal, Monde Ntwasa

    Published 2025-01-01
    “…Background: Ezetimibe is used to treat cardiovascular disease as it blocks the sterol transporter Niemann-Pick C1-Like 1 (NPC1CL1) protein. …”
    Get full text
    Article
  6. 1146

    Increased Peripheral Proinflammatory T Helper Subsets Contribute to Cardiovascular Complications in Diabetic Patients by Ru-xing Zhao, Wen-juan Li, Yi-ran Lu, Jun Qin, Chuan-long Wu, Meng Tian, Tian-yi He, Shou-nan Yi, Dong-qi Tang, Lei Sun, Li Chen

    Published 2014-01-01
    “…The systemic chronic inflammation has been postulated to bridge the increased risk of cardiovascular disease and T2D. We formulated that increased peripheral proinflammatory T helper subsets contributed to the development of cardiovascular complications in diabetic patients. …”
    Get full text
    Article
  7. 1147

    Alterations in genes associated with cytosolic RNA sensing in whole blood are associated with coronary microvascular disease in SLE by Lihong Huo, Arati Naveen Kumar, Gantsetseg Tumurkhuu, Moumita Bose, Daniel S. Berman, Daniel J. Wallace, Janet Wei, Mariko Ishimori, C. Noel Bairey Merz, Caroline Jefferies

    Published 2025-01-01
    “…Abstract Systemic lupus erythematosus (SLE) patients are 90% women and over three times more likely to die of cardiovascular disease than women in the general population. …”
    Get full text
    Article
  8. 1148

    The Level of hs-CRP in Coronary Artery Ectasia and Its Response to Statin and Angiotensin-Converting Enzyme Inhibitor Treatment by Yilmaz Ozbay, Mehmet Akbulut, Mehmet Balin, Hidayet Kayancicek, Adil Baydas, Hasan Korkmaz

    Published 2007-01-01
    “…C-reactive protein (CRP) which is among the most sensitive markers of systemic inflammation, and elevation of systemic and local levels of this inflammatory marker which has been associated with an increased risk for cardiovascular disease in the obstructive coronary artery disease (O-CAD) are well known, but little was known in CAE. …”
    Get full text
    Article
  9. 1149

    Theory-based mobile phone text messaging intervention for blood pressure control (TEXT4BP) among hypertensive patients in Nepal: study protocol for a feasibility randomised control... by Buna Bhandari, Padmanesan Narasimhan, Abhinav Vaidya, Rohan Jayasuriya

    Published 2020-09-01
    “…Introduction Uncontrolled blood pressure is one of the main risk factors for cardiovascular disease and death in Low-income and middle-income countries. …”
    Get full text
    Article
  10. 1150

    Prevalence and Clinical Characteristics including Patterns of Antihypertensive Drug Administration of the Different Home Blood Pressure Phenotypes in Treated Hypertensive Patients by Chavalit Chotruangnapa, Tossaporn Thammarux, Piyawan Thongdang

    Published 2022-01-01
    “…The multivariable analysis showed the significantly associated factor of MoHT was the presence of previous cardiovascular disease (adjusted OR 5.54, 95% CI (2.02–15.22); p value = 0.001). …”
    Get full text
    Article
  11. 1151

    Genome-Wide Association Study of Metabolic Syndrome in Koreans by Seok Won Jeong, Myungguen Chung, Soo-Jung Park, Seong Beom Cho, Kyung-Won Hong

    Published 2014-12-01
    “…Metabolic syndrome (METS) is a disorder of energy utilization and storage and increases the risk of developing cardiovascular disease and diabetes. To identify the genetic risk factors of METS, we carried out a genome-wide association study (GWAS) for 2,657 cases and 5,917 controls in Korean populations. …”
    Get full text
    Article
  12. 1152

    Association of estimated glucose disposal rate with metabolic syndrome prevalence and mortality risks: a population-based study by Xiaoli Chen, Aihua Li, Qilin Ma

    Published 2025-01-01
    “…Abstract Background Insulin resistance (IR) is a central pathophysiological factor in metabolic syndrome (MetS) and an essential driver of cardiovascular disease (CVD) and mortality. The estimated glucose disposal rate (eGDR) is a reliable marker of IR and has been associated with CVD prognosis. …”
    Get full text
    Article
  13. 1153

    Prevalence and Correlates of Hypertension Unawareness among Lebanese Adults: The Need to Target Those “Left Behind” by Fatima Ghaddar, Lama Hammad, Rania A. Tohme, Tamar Kabakian-Khasholian, Nahla Hwalla, Abla M. Sibai

    Published 2021-01-01
    “…Hypertension unawareness is context-specific, and our understanding of factors associated with it has implications on primary healthcare practices locally and contributes to achieving cardiovascular disease (CVD) targets, globally. In this study, we examine the prevalence and correlates of hypertension unawareness among adult Lebanese population. …”
    Get full text
    Article
  14. 1154

    Comprehensive analysis of disulfidptosis-related genes and the immune microenvironment in heart failure by Linna Zhao, Juanjuan Zhang, Juanjuan Zhang, Qiuhang Song, Cheng Dai, Yiping Qin, Aiying Li, Aiying Li

    Published 2025-01-01
    “…BackgroundHeart failure (HF) is a prevalent cardiovascular disease that currently lacks effective treatment options due to its intricate pathogenesis. …”
    Get full text
    Article
  15. 1155

    Effects of Resistant Starch on Patients with Chronic Kidney Disease: A Systematic Review and Meta-Analysis by Xinyi Du, Jing Wu, Chenlin Gao, Qinqin Tan, Yong Xu

    Published 2022-01-01
    “…Chronic kidney disease (CKD) is a main health problem associated with increased risk of cardiovascular disease, morbidity, and mortality. Recent studies shown that the progression of CKD may be related to the change of intestinal flora. …”
    Get full text
    Article
  16. 1156

    Cardiometabolic deaths in black and white men: Tracing the risks from early- to mid-adulthood by Rebecca Arden Harris, Sameed Ahmed M. Khatana, Judith A. Long

    Published 2025-03-01
    “…We estimated cumulative risk, excess mortality, years of lost life (YLL), and proportion of deaths due to CMD, stratifying by metabolic and cardiovascular disease. Results: Of the 325,134 Black men aged 25 years in the initial cohort, the cumulative risk of cardiometabolic death before age 45 was one in 63 individuals or 1.58 %. …”
    Get full text
    Article
  17. 1157

    4-Methoxycarbonyl Curcumin: A Unique Inhibitor of Both Inflammatory Mediators and Periodontal Inflammation by Ying Gu, Hsi-Ming Lee, Nicole Napolitano, McKenzie Clemens, Yazhou Zhang, Timo Sorsa, Yu Zhang, Francis Johnson, Lorne M. Golub

    Published 2013-01-01
    “…Chronic inflammatory diseases such as periodontitis have been associated with increased risk for various medical conditions including diabetes and cardiovascular disease. Endotoxin (lipopolysaccharide, LPS), derived from gram-negative periodonto-pathogens, can induce the local accumulation of mononuclear cells in the inflammatory lesion, increasing proinflammatory cytokines and matrix metalloproteinases (MMPs). …”
    Get full text
    Article
  18. 1158

    The Relationship between Body Mass Index and the Severity of Coronary Artery Disease in Patients Referred for Coronary Angiography by Anne B. Gregory, Kendra K. Lester, Deborah M. Gregory, Laurie K. Twells, William K. Midodzi, Neil J. Pearce

    Published 2017-01-01
    “…Obesity is associated with an increased risk of cardiovascular disease and may be associated with more severe coronary artery disease (CAD); however, the relationship between body mass index [BMI (kg/m2)] and CAD severity is uncertain and debatable. …”
    Get full text
    Article
  19. 1159

    Joint and independent associations of dietary antioxidant intakes with all-cause and cardiovascular mortality among patients with hypertension: a population-based cohort study by Songfeng Zhao, Yangbin Cao, Hongyi Liu, Aihua Liu

    Published 2025-01-01
    “…Abstract Background The evidence regarding dietary antioxidant intake and all-cause and cardiovascular disease (CVD) mortality among patients with hypertension is scarce. …”
    Get full text
    Article
  20. 1160

    Microbial Characteristics and Functions in Coffee Fermentation: A Review by Xiaojing Shen, Qi Wang, Hongsheng Wang, Guoqing Fang, Ying Li, Jilai Zhang, Kunyi Liu

    Published 2024-12-01
    “…These compounds often relate to the prevention of cardiovascular disease, Alzheimer’s disease, and antibacterial, anti-diabetic, neuroprotection, and anti-cancer activities. …”
    Get full text
    Article